ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
This Quarter Return
-4.05%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$91.4M
AUM Growth
+$91.4M
(+64%)
Cap. Flow
+$37.2M
Cap. Flow
% of AUM
40.67%
Top 10 Holdings %
Top 10 Hldgs %
62.05%
Holding
42
New
9
Increased
17
Reduced
3
Closed
13
Top Buys
| 1 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$8.7M |
| 2 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
$7.48M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$4.42M |
| 4 |
Guardant Health
GH
|
$2.87M |
| 5 |
Fate Therapeutics
FATE
|
$2.67M |
Top Sells
| 1 |
Insmed
INSM
|
$2.72M |
| 2 |
Viatris
VTRS
|
$2.67M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$1.72M |
| 4 |
AbbVie
ABBV
|
$1.68M |
| 5 |
Centene
CNC
|
$1.67M |
Sector Composition
| 1 | Healthcare | 84.87% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARNA
1
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $10.5M | 11.48% | 249,866 +207,178 | +485% | +$8.7M |
|
|
BMY.RT
2
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $9.06M | 9.91% | 2,384,487 +1,968,556 | +473% | +$7.48M |
|
3
Baxter International
BAX
$12.7B
| $6.15M | 6.72% | 75,737 +23,545 | +45% | +$1.91M |
|
|
4
Guardant Health
GH
$8.41B
| $5.32M | 5.82% | 76,438 +41,202 | +117% | +$2.87M |
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $4.62M | 5.05% | 54,676 +20,895 | +62% | +$1.77M |
|
6
PTC Therapeutics
PTCT
$3.92B
| $4.48M | 4.9% | 100,470 +45,062 | +81% | +$2.01M |
|
7
Bio-Rad Laboratories Class A
BIO
$8.06B
| $4.44M | 4.86% | 12,676 +6,325 | +100% | +$2.22M |
|
|
GBT
8
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.42M | 4.84% | +86,577 | New | +$4.42M |
|
9
UnitedHealth
UNH
$281B
| $3.94M | 4.31% | 15,811 +9,397 | +147% | +$2.34M |
|
10
Twist Bioscience
TWST
$1.63B
| $3.8M | 4.15% | 124,120 +69,786 | +128% | +$2.13M |
|
|
MYOK
11
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $3.41M | 3.73% | 72,712 +49,689 | +216% | +$2.33M |
|
12
Ascendis Pharma
ASND
$11.8B
| $3.17M | 3.47% | 28,157 +21,610 | +330% | +$2.43M |
|
13
Amicus Therapeutics
FOLD
$2.34B
| $2.94M | 3.22% | 318,152 +219,434 | +222% | +$2.03M |
|
|
14
Fate Therapeutics
FATE
$120M
| $2.67M | 2.92% | +120,103 | New | +$2.67M |
|
15
Cytokinetics
CYTK
$4.23B
| $2.41M | 2.63% | 204,251 +119,079 | +140% | +$1.4M |
|
|
MNTA
16
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $2.26M | 2.47% | 83,087 +20,502 | +33% | +$558K |
|
17
Tandem Diabetes Care
TNDM
$845M
| $2.08M | 2.27% | 32,292 -11,267 | -26% | -$725K |
|
|
VAR
18
DELISTED
Varian Medical Systems, Inc.
VAR
| $1.8M | 1.96% | 17,484 +11,550 | +195% | +$1.19M |
|
|
NSTG
19
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.79M | 1.96% | +74,501 | New | +$1.79M |
|
|
MRNS
20
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.74M | 1.9% | 855,318 +500,465 | +141% | +$1.02M |
|
21
uniQure
QURE
$896M
| $1.53M | 1.68% | +32,331 | New | +$1.53M |
|
22
10x Genomics
TXG
$1.74B
| $1.53M | 1.68% | +24,603 | New | +$1.53M |
|
23
Sarepta Therapeutics
SRPT
$1.78B
| $1.47M | 1.61% | +15,016 | New | +$1.47M |
|
|
TECX
24
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $1.33M | 1.46% | +85,554 | New | +$1.33M |
|
|
IMMU
25
DELISTED
Immunomedics Inc
IMMU
| $1.24M | 1.36% | +92,147 | New | +$1.24M |
|